Objective To compare the efficacy of covid-19 vaccines between immunocompromised and
immunocompetent people. Design Systematic review and meta-analysis. Data sources …

Background Available data show that COVID-19 vaccines may be less effective in
immunocompromised populations, who are at increased risk of severe COVID-19 …

mRNA vaccines have brought about a great revolution in the vaccine fields owing to their
simplicity and adaptability in antigen design, potential to induce both humoral and cell …

Importance Recipients of solid organ transplant (SOT) experience decreased
immunogenicity after COVID-19 vaccination. Objective To summarize current evidence on …

Knowledge on the immunogenicity of vector-based and mRNA-vaccines in solid organ
transplant recipients is limited. Therefore, SARS-CoV-2–specific T cells and antibodies were …

Background: Recipients of solid organ transplant (SOT) are a high-risk group for severe
SARS-CoV-2 infection. The mortality rate of patients with SOT during the COVID-19 …

A weak humoral response to two-doses of SARS-CoV-2 vaccine was observed in solid
organ transplant (SOT) patients. 1, 2 Preliminary reports suggested the usefulness of a boost …

Rationale & Objective Patients with kidney failure who are receiving maintenance dialysis
have a higher risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS …

With the advent of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
pandemic, several vaccines have been developed to mitigate its spread and prevent …

BACKGROUND Vaccine-elicited adaptive immunity is a prerequisite for control of SARS-
CoV-2 infection. Multiple sclerosis (MS) disease-modifying therapies (DMTs) differentially …